Clinical Trial

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Study acronym: BCG at Home
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 13, 2026 (before its estimated August 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-30; most recent amendment 2026-05-10.
Status change: Not Yet Recruiting → Recruiting 2025-08-09
Trial Details
NCT Number NCT07048496
Lead Sponsor Abramson Cancer Center at Penn Medicine
Collaborators: Blue Cross Blue Shield
Conditions Bladder Cancer
Enrollment 50 participants
Start Date 2025-07-05
Primary Completion 2026-08-05 (estimated)
Study Completion 2026-09-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-13